Quarterly Report III 15/16
September 2015 – May 2016, Diamyd Medical AB (publ), Fiscal year 2015/2016Reporting period, Mar 1, 2016 – May 31, 2016 · Net result amounted to MSEK -18.2 (-7.3), of which impairment of holding in associated company amounted to MSEK -13.5 (0) · Net result per share amounted to SEK -0.8 (-0.3) · Cash flow from operating activities amounted to MSEK -4.3 (-4.8) · Liquid assets and short term investments amounted at the end of the period to MSEK 36.5 (34.2) September 1, 2015 – May 31, 2016 · Net result amounted to MSEK -27.2 (-17.2), of which impairment of holding in